People who have taken experimental peptides report adverse effects including migraines, eye pain, and fatigue, even as Health Secretary Robert F. Kennedy Jr. seeks to loosen regulations and lower barriers to accessing these FDA-unapproved substances. Medical experts warn that vague symptoms from gray market peptides often go unrecognized or unreported.
More than 25 people across four states became ill after receiving glutathione injections, with at least three hospitalized. The CDC is investigating the outbreak linked to dietary supplement-grade glutathione products, and three Texas compounding pharmacies have issued recalls.
Multiple studies released this week show hormone therapy during menopause may reduce heart disease risk and improve mood symptoms, while supplements marketed for menopause lack evidence and contain inconsistent doses. The research comes amid growing attention to the economic costs of menopause symptoms for women.
Researchers at the University of Cape Town have issued a warning about potential health risks associated with pre-workout supplements following a case where an adult patient presented to the emergency unit with chest pain.
A new analysis reveals that many prebiotic sodas, which have surged in popularity with promises of gut health benefits and low-calorie content, may actually contain lower fiber levels and higher sugar content than consumers expect.
Outside advisers to the U.S. Food and Drug Administration narrowly voted to recommend broader access to several unapproved peptides popular in wellness circles, backing a push by HHS Secretary Robert F. Kennedy Jr. despite objections from FDA career scientists about limited safety data and potential conflicts of interest among panelists.
Kratom-related poisonings have increased by 1,200% over the past decade, with proposals to ban or regulate the plant-based substance making headlines across the United States as lawmakers and regulators grapple with safety concerns.